Chatani M, Nose T, Masaki N, Inoue T
Department of Radiation Therapy, Osaka Medical Center for Cancer and Cardiovascular Diseases.
Strahlenther Onkol. 1998 Oct;174(10):504-9. doi: 10.1007/BF03038982.
To investigate prognostic factors and complications after radical hysterectomy followed by postoperative radiotherapy for carcinoma of the uterine cervix.
One hundred twenty-eight patients with T1b-2b carcinoma of the uterine cervix following radical hysterectomy with bilateral pelvic lymphadenectomy and postoperative radiation therapy were reviewed. Pathologic and treatment variables were assessed by multivariate analysis for local recurrence, distant metastases and cause specific survival.
The number of positive nodes (PN) in the pelvis was the strongest predictor of pelvic recurrence and distant metastases. These 2 failure patterns independently affect the cause specific survival. The 5-year cumulative local and distant failure were PN(0): 2% and 12%, PN(1-2): 23% and 25%, PN(2 <): 32% and 57%, respectively (p = 0.0029 and p = 0.0051). The 5-year cause specific survival rates were PN(0): 90%, PN(1-2): 59% and PN(2 <): 42% (p = 0.0001). The most common complication was lymphedema of the foot experienced by one-half of the patients (5-year: 42%, 10-year: 49%).
These results suggest that patients with pathologic T1b-T2b cervix cancer with pelvic lymph node metastases are at high risk of recurrence or metastases after radical hysterectomy with pelvic lymphadenectomy and postoperative irradiation.
探讨子宫颈癌根治性子宫切除术后辅助放疗的预后因素及并发症。
回顾性分析128例子宫颈癌患者,均接受了根治性子宫切除、双侧盆腔淋巴结清扫及术后放疗,病理分期为T1b - 2b。通过多因素分析评估病理及治疗变量与局部复发、远处转移和特定病因生存率的关系。
盆腔阳性淋巴结数目是盆腔复发和远处转移的最强预测因素。这两种失败模式独立影响特定病因生存率。5年累积局部和远处失败率分别为:阳性淋巴结数(PN)为0时:2%和12%;PN为1 - 2时:23%和25%;PN大于2时:32%和57%(p = 0.0029和p = 0.0051)。5年特定病因生存率分别为:PN为0时:90%;PN为1 - 2时:59%;PN大于2时:42%(p = 0.0001)。最常见的并发症是足部淋巴水肿,一半患者出现该症状(5年发生率:42%,10年发生率:49%)。
这些结果表明,病理分期为T1b - T2b且伴有盆腔淋巴结转移的子宫颈癌患者,在接受根治性子宫切除、盆腔淋巴结清扫及术后放疗后,复发或转移风险较高。